4.2 Article

A Biomimetic Human Gut-on-a-Chip for Modeling Drug Metabolism in Intestine

期刊

ARTIFICIAL ORGANS
卷 42, 期 12, 页码 1196-1205

出版社

WILEY
DOI: 10.1111/aor.13163

关键词

Gut-on-a-chip; Caco-2; Intestinal metabolism; Biomimetic; Drug metabolism

资金

  1. Strategic Priority Research Program of the Chinese Academy of Sciences [XDA16020900, XDPB0305]
  2. Key Program of the Chinese Academy of Sciences [KFZD-SW-213]
  3. International Science & Technology Cooperation Program of China [2015DFA00740]
  4. National Key R&D Program of China [2017YFB0405400]
  5. National Natural Science Foundation of China [91543121, 81573394, 31671038, 81603075, 21607151, 81703470]
  6. Innovation Program of Science and Research from the DICP, CAS [DICP TMSR201601]

向作者/读者索取更多资源

Drug metabolism in the intestine is considered to substantially contribute to the overall first-pass metabolism, which has been neglected for a long time. It is highly desirable to develop a reliable model to evaluate drug metabolism in the intestine in vitro. In this work, we made the first attempt to develop a biomimetic human gut-on-a-chip for modeling drug metabolism in intestine. In this chip, constant flow, together with porous nitrocellulose membrane and collagen I, mimics an in vivo-like intestinal microenvironment. The Caco-2 cells grown in the chip formed a compact intestinal epithelial layer with continuous expression of the tight junction protein, ZO-1. Furthermore, higher gene expression of villin, sucrase-isomaltase, and alkaline phosphatase demonstrated that cells in the biomimetic human gut-on-a-chip device were more mature with near-physiological functions compared to the control on planar substrate. In particular, cellular metabolic activity was assessed on different substrates, indicating higher metabolic efficiency of ifosfamide and verapamil in the biomimetic human gut-on-a-chip model. Taken together, our results suggested that this biomimetic human gut-on-a-chip promoted the differentiation of intestinal cells with enhanced functionality by creating a biomimetic 3D microenvironment in vitro. It might offer a bioactive, low-cost, and flexible in vitro platform for studies on intestinal metabolism as well as preclinical drug development.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据